Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Other Non-Current Assets (2020 - 2023)

Historic Other Non-Current Assets for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $459000.0.

  • Cullinan Therapeutics' Other Non-Current Assets fell 21.74% to $459000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $459000.0, marking a year-over-year decrease of 21.74%. This contributed to the annual value of $459000.0 for FY2022, which is 21224.49% up from last year.
  • As of Q3 2023, Cullinan Therapeutics' Other Non-Current Assets stood at $459000.0, which was down 21.74% from $459000.0 recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Other Non-Current Assets ranged from a high of $2.3 million in Q4 2020 and a low of $100000.0 during Q2 2022
  • Its 4-year average for Other Non-Current Assets is $452583.3, with a median of $303000.0 in 2021.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first tumbled by 9360.87% in 2021, then skyrocketed by 35900.0% in 2023.
  • Cullinan Therapeutics' Other Non-Current Assets (Quarter) stood at $2.3 million in 2020, then plummeted by 93.61% to $147000.0 in 2021, then surged by 212.24% to $459000.0 in 2022, then changed by 0.0% to $459000.0 in 2023.
  • Its Other Non-Current Assets stands at $459000.0 for Q3 2023, versus $459000.0 for Q2 2023 and $459000.0 for Q1 2023.